Cassava Sciences GAAP EPS of -$0.57 beats by $0.09 Posted on March 3, 2025 by wpadmin Cassava Sciences press release (NASDAQ:SAVA): Q4 GAAP EPS of -$0.57 beats by $0.09. At December 31, 2024, cash and cash equivalents were $128.6 million, with no debt.